A 72-year-old woman with hypertension and diabetes mellitus type 2 is found to have a left ventricular ejection fraction (LVEF) of 38% on routine echocardiography during evaluation for exertional dyspnea. She denies orthopnea, paroxysmal nocturnal dyspnea, or peripheral edema. Physical examination is unremarkable except for mild hypertension (BP 148/92 mmHg). Serum creatinine is 1.1 mg/dL, potassium 4.2 mEq/L. She is currently on amlodipine and metformin. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has **asymptomatic reduced ejection fraction (HFrEF)** — LVEF 38% without signs or symptoms of heart failure. She has risk factors (hypertension, diabetes) and is on a calcium channel blocker, which is not cardioprotective in HF. ## Rationale for Correct Answer **Key Point:** All patients with LVEF ≤40% (whether symptomatic or asymptomatic) should receive **ACE inhibitor (or ARB) and beta-blocker** therapy, regardless of symptoms. These drugs reduce mortality and slow disease progression even in asymptomatic stages [cite:Harrison 21e Ch 297]. **High-Yield:** The landmark studies (SOLVD, CIBIS, MERIT-HF) demonstrated that ACE-I and beta-blockers reduce mortality and HF hospitalizations in both symptomatic and asymptomatic HFrEF. This is now Class I evidence. **Clinical Pearl:** Asymptomatic HFrEF (Stage B) is a critical intervention point. Early initiation of GDMT can prevent or delay progression to symptomatic HF (Stage C). **Mnemonic: ABCD of HF Stages** - **A** = At risk (hypertension, diabetes, CAD) — lifestyle modification - **B** = Asymptomatic LV dysfunction (LVEF ≤40%) — **ACE-I + BB** - **C** = Symptomatic HF — ACE-I + BB + diuretics ± ARNI - **D** = Refractory/advanced HF — consider transplant, VAD, palliative care ## Management Algorithm for Asymptomatic HFrEF ```mermaid flowchart TD A[LVEF ≤40%<br/>No Symptoms]:::outcome --> B{Ischemic<br/>Etiology?}:::decision B -->|Suspected| C[Coronary Angiography<br/>Consider Revascularization]:::action B -->|Not Suspected| D[Start ACE-I/ARB<br/>+ Beta-Blocker]:::action C --> E[Optimize GDMT<br/>ACE-I/ARB + BB]:::action D --> E E --> F[Cardiology Follow-up<br/>in 4–6 weeks]:::action F --> G[Repeat Echo<br/>if Symptoms Develop]:::action ``` ## Why Diuretics Are Not First-Line in Asymptomatic HFrEF **Diuretics are indicated ONLY if:** - Signs/symptoms of volume overload (orthopnea, edema, elevated JVP) - Pulmonary or peripheral congestion on imaging This patient has **no congestion**, so diuretics are unnecessary and may cause electrolyte abnormalities or renal dysfunction without benefit. ## Addressing the Ischemic Question While coronary angiography may eventually be warranted to assess for CAD (especially given age, hypertension, diabetes), it is **not the immediate next step**. The priority is: 1. Initiate GDMT (ACE-I/BB) — these are indicated regardless of CAD status 2. Refer to cardiology for risk stratification and possible stress testing or angiography 3. Cardiology will decide on need for angiography based on symptom severity, risk profile, and imaging findings